163 related articles for article (PubMed ID: 37834003)
1. The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma.
Platonova N; Lazzari E; Colombo M; Falleni M; Tosi D; Giannandrea D; Citro V; Casati L; Ronchetti D; Bolli N; Neri A; Torricelli F; Crews LA; Jamieson CHM; Chiaramonte R
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834003
[TBL] [Abstract][Full Text] [Related]
2. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2.
Choi K; Ahn YH; Gibbons DL; Tran HT; Creighton CJ; Girard L; Minna JD; Qin FX; Kurie JM
J Biol Chem; 2009 Jun; 284(26):17766-74. PubMed ID: 19398556
[TBL] [Abstract][Full Text] [Related]
3. Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells.
Chiron D; Maïga S; Descamps G; Moreau P; Le Gouill S; Marionneau S; Ouiller T; Moreaux J; Klein B; Bataille R; Amiot M; Pellat-Deceunynck C
Blood Cells Mol Dis; 2012 Apr; 48(4):247-53. PubMed ID: 22341562
[TBL] [Abstract][Full Text] [Related]
4. NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma.
Fiaschetti G; Schroeder C; Castelletti D; Arcaro A; Westermann F; Baumgartner M; Shalaby T; Grotzer MA
Acta Neuropathol Commun; 2014 Apr; 2():39. PubMed ID: 24708907
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
[TBL] [Abstract][Full Text] [Related]
6. Anti-Jagged-1 immunotherapy in cancer.
Pancewicz J; Niklinska W; Eljaszewicz A
Adv Med Sci; 2022 Sep; 67(2):196-202. PubMed ID: 35421813
[TBL] [Abstract][Full Text] [Related]
7. Assemblies of JAG1 and JAG2 determine tracheobronchial cell fate in mucosecretory lung disease.
Reynolds SD; Hill CL; Alsudayri A; Lallier SW; Wijeratne S; Tan ZH; Chiang T; Cormet-Boyaka E
JCI Insight; 2022 Aug; 7(15):. PubMed ID: 35819850
[TBL] [Abstract][Full Text] [Related]
8. β-site amyloid precursor protein cleaving enzyme 1(BACE1) regulates Notch signaling by controlling the cleavage of Jagged 1 (Jag1) and Jagged 2 (Jag2) proteins.
He W; Hu J; Xia Y; Yan R
J Biol Chem; 2014 Jul; 289(30):20630-7. PubMed ID: 24907271
[TBL] [Abstract][Full Text] [Related]
9. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
Katoh M; Katoh M
Int J Mol Med; 2006 Apr; 17(4):681-5. PubMed ID: 16525728
[TBL] [Abstract][Full Text] [Related]
10. Disrupting Jagged1-Notch signaling impairs spatial memory formation in adult mice.
Sargin D; Botly LC; Higgs G; Marsolais A; Frankland PW; Egan SE; Josselyn SA
Neurobiol Learn Mem; 2013 Jul; 103():39-49. PubMed ID: 23567106
[TBL] [Abstract][Full Text] [Related]
11. NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth.
Kangsamaksin T; Murtomaki A; Kofler NM; Cuervo H; Chaudhri RA; Tattersall IW; Rosenstiel PE; Shawber CJ; Kitajewski J
Cancer Discov; 2015 Feb; 5(2):182-97. PubMed ID: 25387766
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.
Houde C; Li Y; Song L; Barton K; Zhang Q; Godwin J; Nand S; Toor A; Alkan S; Smadja NV; Avet-Loiseau H; Lima CS; Miele L; Coignet LJ
Blood; 2004 Dec; 104(12):3697-704. PubMed ID: 15292061
[TBL] [Abstract][Full Text] [Related]
13. No evidence for a functional role of bi-directional Notch signaling during angiogenesis.
Liebler SS; Feldner A; Adam MG; Korff T; Augustin HG; Fischer A
PLoS One; 2012; 7(12):e53074. PubMed ID: 23300864
[TBL] [Abstract][Full Text] [Related]
14. Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.
Oon CE; Bridges E; Sheldon H; Sainson RCA; Jubb A; Turley H; Leek R; Buffa F; Harris AL; Li JL
Oncotarget; 2017 Jun; 8(25):40115-40131. PubMed ID: 28445154
[TBL] [Abstract][Full Text] [Related]
15. The Notch ligand JAG1 is required for sensory progenitor development in the mammalian inner ear.
Kiernan AE; Xu J; Gridley T
PLoS Genet; 2006 Jan; 2(1):e4. PubMed ID: 16410827
[TBL] [Abstract][Full Text] [Related]
16. Jagged 1 regulates the restriction of Sox2 expression in the developing chicken inner ear: a mechanism for sensory organ specification.
Neves J; Parada C; Chamizo M; Giráldez F
Development; 2011 Feb; 138(4):735-44. PubMed ID: 21266409
[TBL] [Abstract][Full Text] [Related]
17. Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance.
Colombo M; Garavelli S; Mazzola M; Platonova N; Giannandrea D; Colella R; Apicella L; Lancellotti M; Lesma E; Ancona S; Palano MT; Barbieri M; Taiana E; Lazzari E; Basile A; Turrini M; Pistocchi A; Neri A; Chiaramonte R
Haematologica; 2020 Jul; 105(7):1925-1936. PubMed ID: 31582544
[TBL] [Abstract][Full Text] [Related]
18. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
Nishina S; Shiraha H; Nakanishi Y; Tanaka S; Matsubara M; Takaoka N; Uemura M; Horiguchi S; Kataoka J; Iwamuro M; Yagi T; Yamamoto K
Oncol Rep; 2011 Sep; 26(3):523-31. PubMed ID: 21637926
[TBL] [Abstract][Full Text] [Related]
19. Two Notch ligands, Dll1 and Jag1, are differently restricted in their range of action to control neurogenesis in the mammalian spinal cord.
Ramos C; Rocha S; Gaspar C; Henrique D
PLoS One; 2010 Nov; 5(11):e15515. PubMed ID: 21124801
[TBL] [Abstract][Full Text] [Related]
20. A role for Jag2 in promoting uveal melanoma dissemination and growth.
Asnaghi L; Handa JT; Merbs SL; Harbour JW; Eberhart CG
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):295-306. PubMed ID: 23211831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
